Birdwatch Archive

Birdwatch Note Rating

2025-02-15 20:25:17 UTC - SOMEWHAT_HELPFUL

Rated by Participant: 33ED8D29FEB5589E241DFDD1EF8C3947E3D3CD61E3107E57C950D74D4108B434
Participant Details

Original Note:

China’s advancements in diabetes treatment are promising, their integration into U.S. medical practice depends on thorough validation through clinical trials and regulatory approval. The suggestion that financial motivations are hindering adoption lacks substantiated evidence. https://medium.com/%40thechinaacademy/chinas-diabetes-cure-america-s-last-hope-15f231cdaec6

All Note Details

Original Tweet

All Information

  • noteId - 1890855351509221687
  • participantId -
  • raterParticipantId - 33ED8D29FEB5589E241DFDD1EF8C3947E3D3CD61E3107E57C950D74D4108B434
  • createdAtMillis - 1739651117843
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - SOMEWHAT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 189085535150922168733ED8D29FEB5589E241DFDD1EF8C3947E3D3CD61E3107E57C950D74D4108B434